Ignite Creation Date:
2025-12-24 @ 1:16 PM
Ignite Modification Date:
2026-01-03 @ 10:47 AM
Study NCT ID:
NCT00672295
Status:
COMPLETED
Last Update Posted:
2012-12-28
First Post:
2008-05-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PH I SRC Kinase, Dasatinib Combo Paclitaxel & Carboplatin in Pts w Ovarian, Peritoneal, & Tubal Cancer
Sponsor:
AA Secord
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-08
Start Date Type:
None
Primary Completion Date:
2011-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-11
Completion Date Type:
ACTUAL
First Submit Date:
2008-05-04
First Submit QC Date:
None
Study First Post Date:
2008-05-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-12-27
Last Update Post Date:
2012-12-28
Last Update Post Date Type:
ESTIMATED